Want to see LFST full AI Analyst Report?
Total Valuation
Lifestance Health Group has a market cap or net worth of $4.55B. The enterprise value is $4.40K.
Market Cap$4.55B
Enterprise Value$4.40K
Share Statistics
Lifestance Health Group has 382,055,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding382,055,600
Owned by Insiders51.30%
Owned by Institutions10.47%
Financial Efficiency
Lifestance Health Group’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.94%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.94%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee167.56K
Profits Per Employee1.14K
Employee Count8,500
Asset Turnover0.65
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lifestance Health Group is 88.3. Lifestance Health Group’s PEG ratio is -1.96.
PE Ratio88.3
PS Ratio1.91
PB Ratio1.79
Price to Fair Value1.79
Price to FCF24.70
Price to Operating Cash Flow21.53
PEG Ratio-1.96
Income Statement
In the last 12 months, Lifestance Health Group had revenue of 1.42B and earned 9.66M in profits. Earnings per share was 0.03.
Revenue1.42B
Gross Profit461.10M
Operating Income24.15M
Pretax Income12.36M
Net Income9.66M
EBITDA78.78M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 217.87M and capital expenditures -7.84M, giving a free cash flow of 210.03M billion.
Operating Cash Flow217.87M
Free Cash Flow210.03M
Free Cash Flow per Share0.55
Dividends & Yields
Lifestance Health Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change122.44%
50-Day Moving Average10.01
200-Day Moving Average7.62
Relative Strength Index (RSI)60.79
Average Volume (3m)3.74M
Important Dates
Lifestance Health Group upcoming earnings date is Nov 5, 2026, After Close (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Lifestance Health Group as a current ratio of 1.65, with Debt / Equity ratio of 13.58%
Current Ratio1.65
Quick Ratio1.65
Debt to Market Cap0.07
Net Debt to EBITDA-0.69
Interest Coverage Ratio2.07
Taxes
In the past 12 months, Lifestance Health Group has paid 2.70M in taxes.
Income Tax2.70M
Effective Tax Rate0.22
Enterprise Valuation
Lifestance Health Group EV to EBITDA ratio is 33.80, with an EV/FCF ratio of 24.20.
EV to Sales1.87
EV to EBITDA33.80
EV to Free Cash Flow24.20
EV to Operating Cash Flow18.22
Balance Sheet
Lifestance Health Group has $225.94M in cash and marketable securities with $200.66M in debt, giving a net cash position of $25.28M billion.
Cash & Marketable Securities$225.94M
Total Debt$200.66M
Net Cash$25.28M
Net Cash Per Share$0.07
Tangible Book Value Per Share$0.13
Margins
Gross margin is 25.84%, with operating margin of 1.70%, and net profit margin of 0.68%.
Gross Margin25.84%
Operating Margin1.70%
Pretax Margin0.87%
Net Profit Margin0.68%
EBITDA Margin5.53%
EBIT Margin1.69%
Analyst Forecast
The average price target for Lifestance Health Group is $12.56, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.56
Price Target Upside15.19% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast20.38%
EPS Growth Forecast―